Terms: = Prostate cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Treatment
19 results:
1. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
2. Apoptotic Potential of Glucomoringin Isothiocyanate (GMG-ITC) Isolated from
Abd Karim NA; Adam AHB; Jaafaru MS; Rukayadi Y; Abdull Razis AF
Molecules; 2023 Apr; 28(7):. PubMed ID: 37049977
[TBL] [Abstract] [Full Text] [Related]
3. Synthesize of Bi
Moradi A; Abdihaji M; Kouchaksaraie SB; Alkinani TA; Mahmoudi A; Davoudi A; Dashtmiani W; Ghezeljeh SM; Aghajani S; Ghasemian R; Taramsari SM; Majlesi A; Niyaki ZM; Salehzadeh A
Sci Rep; 2022 Dec; 12(1):21245. PubMed ID: 36482061
[TBL] [Abstract] [Full Text] [Related]
4. Somatic Features of Response and Relapse in Non-muscle-invasive Bladder cancer Treated with Bacillus Calmette-Guérin Immunotherapy.
Bacon JVW; Müller DC; Ritch E; Annala M; Dugas SG; Herberts C; Vandekerkhove G; Seifert H; Zellweger T; Black PC; Bubendorf L; Wyatt AW; Rentsch CA
Eur Urol Oncol; 2022 Dec; 5(6):677-686. PubMed ID: 34895867
[TBL] [Abstract] [Full Text] [Related]
5. Pelvic magnetic resonance imaging parameters predict urinary incontinence after robot-assisted radical prostatectomy.
Sadahira T; Mitsui Y; Araki M; Maruyama Y; Wada K; Edamura K; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Low Urin Tract Symptoms; 2019 May; 11(3):122-126. PubMed ID: 30548814
[TBL] [Abstract] [Full Text] [Related]
6. Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology.
Broeke NC; Peterson J; Lee J; Martin PR; Farag A; Gomez JA; Moussa M; Gaed M; Chin J; Pautler SE; Ward A; Bauman G; Bartha R; Scholl TJ
J Magn Reson Imaging; 2019 May; 49(5):1409-1419. PubMed ID: 30430700
[TBL] [Abstract] [Full Text] [Related]
7. Targeted Next-Generation Sequencing in Men with Metastatic prostate cancer: a Pilot Study.
Barata PC; Mendiratta P; Heald B; Klek S; Grivas P; Sohal DPS; Garcia JA
Target Oncol; 2018 Aug; 13(4):495-500. PubMed ID: 29974386
[TBL] [Abstract] [Full Text] [Related]
8. Quantification of Total and Intracellular Sodium Concentration in Primary prostate cancer and Adjacent Normal prostate Tissue With Magnetic Resonance Imaging.
Barrett T; Riemer F; McLean MA; Kaggie J; Robb F; Tropp JS; Warren A; Bratt O; Shah N; Gnanapragasam VJ; Gilbert FJ; Graves MJ; Gallagher FA
Invest Radiol; 2018 Aug; 53(8):450-456. PubMed ID: 29969108
[TBL] [Abstract] [Full Text] [Related]
9. Health-Related Quality of Life in 536 Long-Term prostate cancer Survivors after treatment with Leuprorelin Acetate: A Combined Retrospective and Prospective Analysis.
Hammerer PG; Wirth MP;
Urol Int; 2018; 100(1):72-78. PubMed ID: 29183006
[TBL] [Abstract] [Full Text] [Related]
10. Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder cancer.
Vandekerkhove G; Todenhöfer T; Annala M; Struss WJ; Wong A; Beja K; Ritch E; Brahmbhatt S; Volik SV; Hennenlotter J; Nykter M; Chi KN; North S; Stenzl A; Collins CC; Eigl BJ; Black PC; Wyatt AW
Clin Cancer Res; 2017 Nov; 23(21):6487-6497. PubMed ID: 28760909
[No Abstract] [Full Text] [Related]
11. EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment.
Tsai LC; Hsieh HY; Lu KY; Wang SY; Mi FL
Nanomedicine (Lond); 2016 Jan; 11(1):9-30. PubMed ID: 26654241
[TBL] [Abstract] [Full Text] [Related]
12. Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant prostate cancer Pretreated With Docetaxel Chemotherapy: A prostate cancer Clinical Trial Consortium Study.
Vaishampayan U; Shevrin D; Stein M; Heilbrun L; Land S; Stark K; Li J; Dickow B; Heath E; Smith D; Fontana J
Urology; 2015 Dec; 86(6):1206-11. PubMed ID: 26375845
[TBL] [Abstract] [Full Text] [Related]
13. AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and tsc1/tsc2.
Lin HP; Lin CY; Huo C; Jan YJ; Tseng JC; Jiang SS; Kuo YY; Chen SC; Wang CT; Chan TM; Liou JY; Wang J; Chang WS; Chang CH; Kung HJ; Chuu CP
Oncotarget; 2015 Sep; 6(29):27097-112. PubMed ID: 26318033
[TBL] [Abstract] [Full Text] [Related]
14. Multivariate analysis of factors predicting prostate dose in intensity-modulated radiotherapy.
Tomita T; Nakamura M; Hirose Y; Kitsuda K; Notogawa T; Miki K; Nakamura K; Ishigaki T
Med Dosim; 2014; 39(4):360-5. PubMed ID: 25155214
[TBL] [Abstract] [Full Text] [Related]
15. A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway.
Hsu JL; Liu SP; Lee CC; Hsu LC; Ho YF; Huang HS; Guh JH
Naunyn Schmiedebergs Arch Pharmacol; 2014 Oct; 387(10):979-90. PubMed ID: 25005758
[TBL] [Abstract] [Full Text] [Related]
16. Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate.
Maund SL; Nolley R; Peehl DM
Lab Invest; 2014 Feb; 94(2):208-21. PubMed ID: 24296879
[TBL] [Abstract] [Full Text] [Related]
17. Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.
Keshari KR; Sriram R; Van Criekinge M; Wilson DM; Wang ZJ; Vigneron DB; Peehl DM; Kurhanewicz J
Prostate; 2013 Aug; 73(11):1171-81. PubMed ID: 23532911
[TBL] [Abstract] [Full Text] [Related]
18. Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy.
Smeenk RJ; Hoffmann AL; Hopman WP; van Lin EN; Kaanders JH
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):636-44. PubMed ID: 22137024
[TBL] [Abstract] [Full Text] [Related]
19. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
Xu Y; Iyengar S; Roberts RL; Shappell SB; Peehl DM
J Cell Physiol; 2003 Jul; 196(1):131-43. PubMed ID: 12767049
[TBL] [Abstract] [Full Text] [Related]
